Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD®immunomodulatory drug pomalidomide-Reference-Cited by-同舟云学术

Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD®immunomodulatory drug pomalidomide

Published:2015-10-12 Issue:5 Volume:171 Page:798-812
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Das Deepika S.¹,Ray Arghya¹,Song Yan¹,Richardson Paul¹,Trikha Mohit²,Chauhan Dharminder¹,Anderson Kenneth C.¹

Affiliation:

1. LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center; Department of Medical Oncology; Dana-Farber Cancer Institute; Harvard Medical School; Boston MA USA

2. Triphase Accelerator; San Diego CA USA

Funder

National Institutes of Health Specialized Programs of Research Excellence (SPORE)

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13780/fullpdf

Reference57 articles.

1. Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions;Anderson;Experimental Hematology,2007

2. The 39th David A. Karnofsky Lecture: bench-to-bedside translation of targeted therapies in multiple myeloma;Anderson;Journal of Clinical Oncology,2012

3. Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation;Arendt;Proceedings of the National Academy of Sciences of the United States of America,1997

4. Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib;Atrash;Blood Cancer Journal,2015

5. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome;Avet-Loiseau;Blood,2007

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma;Critical Reviews in Oncology/Hematology;2023-08

2. LY103, a pomalidomide derivative, alleviates taxol resistance in NSCLC via energy metabolism crosstalk and tumor microenvironment intervention;Bioorganic Chemistry;2023-07

3. Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma;International Journal of Molecular Sciences;2023-01-31

4. Design, synthesis, and biological evaluation of a novel series of 2-(2,6-dioxopiperidin-3-yl)isoquinoline-1,3(2H,4H)-dione derivatives as cereblon modulators;Journal of Enzyme Inhibition and Medicinal Chemistry;2022-06-14

5. Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells;Frontiers in Oncology;2022-05-11